Following an earlier report in 2014 of disappointing preliminary results from a phase III clinical trial of Gilenya (fingolimod)

MS Research Australia is delighted to announce that $1.834 in funding has been awarded to new research projects

Many countries all over the world face the same problem as Australia: the prospect of an even smaller

Following the recent Progress in MS Research Conference, a public lecture was held to share the exciting MS

MS Research Australia recently published the second of two reports which take stock of how far the MS

A clinical trial of sex hormone estriol (oestrogen) supplementation in women with MS has not found a definitive

Low levels of vitamin D, UV radiation, and sun exposure are well established risk factors for MS. However,

It is known that people develop MS due to a combination of risk genes and environmental factors. One

Last week saw the biggest event on the international MS research calendar, the 2015 European Committee for Treatment